Skip to main content

Targeted Imaging of VCAM-1 mRNA in a Mouse Model of Laser-Induced Choroidal Neovascularization Using Antisense Hairpin-DNA-Functionalized Gold-Nanoparticles.

Citation
Uddin, M. I., et al. “Targeted Imaging Of Vcam-1 Mrna In A Mouse Model Of Laser-Induced Choroidal Neovascularization Using Antisense Hairpin-Dna-Functionalized Gold-Nanoparticles.”. Molecular Pharmaceutics, pp. 5514-5520.
Center Vanderbilt University
Author Md Imam Uddin, Tyler C Kilburn, Rong Yang, Gary W McCollum, David W Wright, John S Penn
Keywords LCNV, VCAM-1 mRNA, gold nanoparticle, hairpin-DNA, imaging
Abstract

Mouse laser-induced choroidal neovascularization (mouse LCNV) recapitulates the "wet" form of human age-related macular degeneration (AMD). Vascular cell adhesion molecule-1 (VCAM-1) is a known inflammatory biomarker, and it increases in the choroidal neovascular tissues characteristic of this experimental model. We have designed and constructed gold nanoparticles (AuNPs) functionalized with hairpin-DNA that incorporates an antisense sequence complementary to VCAM-1 mRNA (AS-VCAM-1 hAuNPs) and tested them as optical imaging probes. The 3' end of the hairpin is coupled to a near-infrared fluorophore that is quenched by the AuNP surface via Förster resonance energy transfer (FRET). Hybridization of the antisense sequence to VCAM-1 mRNA displaces the fluorophore away from the AuNP surface, inducing fluorescent activity. In vitro testing showed that hAuNPs hybridize to an exogenous complementary oligonucleotide within a pH range of 4.5-7.4, and that they are stable at reduced pH. LCNV mice received tail-vein injections of AS-VCAM-1 hAuNPs. Hyperspectral imaging revealed the delivery of AS-VCAM-1 hAuNPs to excised choroidal tissues. Fluorescent images of CNV lesions were obtained, presumably in response to the hybridization of AS-hAuNPs to LCNV-induced VCAM-1 mRNA. This is the first demonstration of systemic delivery of hAuNPs to ocular tissues to facilitate mRNA imaging of any target.

Year of Publication
2018
Journal
Molecular pharmaceutics
Volume
15
Issue
12
Number of Pages
5514-5520
Date Published
12/2018
ISSN Number
1543-8392
DOI
10.1021/acs.molpharmaceut.8b00661
Alternate Journal
Mol. Pharm.
PMID
30350640
PMCID
PMC7135968
Download citation